新诊断的肺癌中大脑转移:流行病学和条件生存
1Department of Cardiothoracic Surgery, Yuyao People's Hospital, Yuyao, China.
Translational cancer research
|November 11, 2024
概括
大脑转移的肺癌 (LCBM) 影响每10万人中有5.82人. 一个新的名图模型为LCBM患者提供了个性化的生存预测.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 大脑转移是非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 的常见并发症.
- 脑转移的肺癌 (LCBM) 显著增加了患者的发病率和死亡率.
- 了解LCBM发生率和生存率对于患者护理至关重要.
研究的目的:
- 确定在美国发生的脑转移性肺癌 (LCBM) 的发病率和存活率.
- 为LCBM患者开发一个动态的预后模型.
主要方法:
- 从SEER数据库 (2010-2015) 中对9,212名LCBM患者的分析.
- 使用卡普兰-梅尔和CS公式计算发病率,相对存活率和条件存活率 (CS).
- 通过LASSO回归和Cox回归进行预后因子识别,从而获得基于CS的名图.
主要成果:
- 经年龄调整后的LCBM发病率为每10万人中5.82,略有下降.
- 随着年龄的增加,生存率下降.
- 根据生存时间 (1-4年) 的计算,5年条件生存率从3%提高到73%.
- 关键预测因素包括年龄,性别,种族,瘤特征和治疗方式.
结论:
- 该研究提供了对LCBM的流行病学见解.
- 开发了一种基于CS的新型名ogram,用于动态和个性化的预后预测.
- 诺米图为LCBM患者提供临床上有价值的实时生存估计.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


